Pablo Bedano works in the field of Oncology. He went to medical school at Indiana University School of Medicine. Indiana University School of Medicine has a rank of 45 in research and a 47 in primary care He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Indianapolis Monthly". Pablo Bedano is a published doctor. He published 6 publications, including: 'Paclitaxel plus bevacizumab in patients with chemosensitive relapsed small cell lung cancer: a safety, feasibility, and efficacy study from the Hoosier Oncology Group.' Dr. Pablo M. Bedano accepts all Medicare patients.
NPI NUMBER | 1063551240 | |
NPPES Provider LastName | BEDANO | |
NPPES Provider FirstName | PABLO | |
NPPES Provider ZIPCode | 462561698 | |
NPPES Provider State | IN | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 1514.0 | |
Distinct Opioid Count | 6.0 | |
Opioid Claim Count | 218.0 | |
Percent Opioid Claims | 14.4 |
National Provider Identifier [NPI] | 1063551240 |
Last Name Of The Provider | BEDANO |
First Name Of The Provider | PABLO |
View All |